Develops minimally invasive cardiovascular medical devices and advances them through engineering, regulatory pathways, and clinical trials for future commercialization.
Geographic Exposure
Not disclosed
Geographic data unavailable
Revenue Drivers
End Markets
Hospitals and medical centers
Interventional cardiologists and catheterization labs
Patients with mitral valve regurgitation
Medical device distributors and strategic partners
Specializations
Minimally invasive transcatheter proceduresTranscatheter mitral valve replacement (TMVR)Embolic protection devices for catheterizationFirst-in-human clinical trialsFDA 510(k) clearance processCE Mark conformity assessment+4 more
